methylation-specific PCR
Company researchers have shown that EpiDirect can detect and quantify 5mC without bisulfite treatment, demonstrating it on a promoter in human brain tumor samples.
Through a US-based subsidiary, the South Korean firm has received breakthrough device designation for its bladder cancer test that could accelerate it to market.
Inex Innovate to Launch PCR-Based Endometrial Cancer Detection Test
The Singapore-based company plans to launch the epiHera test in August, following interim results from a clinical study with researchers at the Chinese University of Hong Kong.
BGI Genomics, Zentya Partner to Launch PCR Fecal Test for Colorectal Cancer in Slovakia
ColoTect 1.0 is a fecal assay that can trace abnormal colorectal cancer DNA-methylation biomarkers from fecal samples using methylation-specific PCR technology.
The company aims to release an initial tissue-based prognostic this year, with a less-invasive sponge-sampling version for screening high-risk individuals to follow in 2023.